Johnson & Johnson has proposed a $5.5 billion settlement to resolve tens of thousands of claims alleging its talc products caused ovarian cancer. If approved, the deal could bring a lengthy and costly legal dispute closer to an end, while avoiding further individual trials.

The proposal is part of the company’s broader effort to settle litigation linked to talc-based baby powder and other products. Johnson & Johnson has consistently denied that its talc products cause cancer, and any settlement would not necessarily amount to an admission of wrongdoing.